Technical advances,
especially in the field of biotechnology, have led to the development of
several next generation preventive vaccines, including recombinant vaccines,
viral vector based vaccines and DNA vaccines, which have been demonstrated to
elicit powerful immune responses, resulting in the development of immunological
memory.
To order this 250+ page report, which features 85+ figures
and 125+ tables, please visit this link
The USD 94 billion
(by 2030) financial opportunity within the global preventive vaccine market has
been analyzed across the following segments:
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
§
The Global Preventive
Vaccines Market, 2020-2030 report features the
following companies, which we identified to be key players in this domain:
§
§
§
§
§
§
§
§
§
§
Table of Contents
1. Preface
4. Market Landscape
5. Company Competitiveness Analysis
6. Company Profiles
7. Clinical Trial Analysis
8. Ongoing Vaccine Development Initiatives for Complex
Conditions
9. Funding and Investment Analysis
10. Market Sizing and Opportunity Analysis
11. Case-in-Point: Contract Manufacturing of Vaccines
12. Concluding Remarks
13. Executive Insights
14. Appendix 1: Tabulated Data
15. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
